Reviews

BreezeMeds is a telehealth weight-loss brand operated by Breezemeds, Inc., servicing all 50 states. Care is matched through the Lion MD physician network, led by Dr. Ana Lisa Carr, MD (NPI 1689841744) and Dr. Kelly Tenbrink, MD (NPI 1346482684), per BreezeMeds’ own FAQ. BreezeMeds is LegitScript certified, the telehealth industry’s most recognized third-party compliance credential, and accepts FSA and HSA cards for payment. BreezeMeds offers compounded medication only, in three formats: a weekly semaglutide injection starting at $199/month, a weekly tirzepatide injection starting at $399/month, and a daily oral semaglutide tablet starting at $299/month. It does not dispense FDA-approved brand-name GLP-1 medications. Prescriptions are filled by one of four named pharmacies: Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, and Casa Pharma Rx.

SnagRx is a telehealth weight-loss brand operated by Modern Metabolic Medicine, Inc., based in Wilmington, Delaware. Medical care is provided by OpenLoop Health, a network of US-licensed physicians who review each patient’s intake and determine eligibility for GLP-1 treatment; OpenLoop’s clinicians retain the final decision on whether to prescribe. SnagRx also has its own medical director, a practicing physician who reviews the doctor and pharmacy network for safety. The brand reports 125,000+ customers and is LegitScript certified, meaning its pharmacy, doctor network, and software providers have been independently verified for compliance. SnagRx offers compounded semaglutide and compounded tirzepatide only; it does not dispense FDA-approved brand-name GLP-1 medications. Prescriptions are filled by one of four named, US-based 503A compounding pharmacies (RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy, and Triad Rx), which prepare medication for individual patients under state pharmacy board licensing and federal compounding law. SnagRx is available in every US state except Louisiana; in Nebraska, service is limited to patients 19 and older.

Lttl is a telehealth platform offering compounded semaglutide and tirzepatide for weight loss, alongside microdose GLP-1 options and a separate lineup of longevity peptides, including Sermorelin, NAD+ (injectable, nasal spray, or oral), glutathione, MIC B12, L-carnitine, and methylene blue. Every plan starts with a free, two-minute online health assessment. A licensed U.S. clinician reviews the answers and builds a personalized treatment plan before any prescription is issued — Lttl is explicit that not every applicant is approved, since clinicians retain full discretion to decline treatment that isn’t medically appropriate. Lttl works with FDA-registered pharmacy partners and describes itself as LegitScript verified. The company states plainly that its compounded medications “are produced in FDA-registered facilities but are not FDA-approved and have not been evaluated by the FDA for safety, efficacy, or quality.” Lttl operates without insurance billing or long-term contracts. Members can pay with FSA/HSA funds, and the company advertises “no hidden fees” and the ability to cancel a subscription at any time.

Pallas Health is a telehealth technology platform operated by Brentmoor, Inc. Pallas doesn’t employ clinicians directly; care is delivered by Lion MD, a nationwide network of independently licensed U.S. physicians, coordinated through the CareValidate clinical-operations platform. Medical leadership is named and independently verifiable: Dr. Ana Lisa Carr, MD (board-certified in family, obesity, and addiction medicine) and Dr. Kelly Tenbrink, MD (board-certified in emergency medicine), both with NPI numbers published on Pallas’s own Clinical Disclosures page. Pallas reports serving over 200,000 patients and holds a 4.8-out-of-5 rating from more than 2,400 member reviews. Unlike most compounded-only competitors, Pallas offers a genuine choice: FDA-approved brand-name GLP-1 medications, or compounded semaglutide and tirzepatide, prescribed only when a clinician determines it’s clinically appropriate. Compounded prescriptions are filled by one of six named, U.S.-licensed compounding pharmacies depending on medication and state. Pallas is LegitScript certified and publishes an unusually detailed compliance page covering its provider network, dispensing pharmacies, and data-handling practices — more transparent than most brands we’ve reviewed in this category.

7Hume Care (marketed as HumeCare+) is a telehealth weight loss company that connects members with an independent network of licensed physicians for compounded GLP-1 treatment. Per its own Terms of Service, Hume Care “does not provide medical advice or clinical services” and describes itself as “a technology and administrative services platform only”; all medical evaluations, prescribing decisions, and ongoing treatment are instead handled by a separate, independent “Clinical Network” of licensed physicians. HumeCare+ offers compounded semaglutide (as an injection or a daily oral pill) and compounded tirzepatide (injection only, including a lower-dose “microdose” option), paired with glycine, B12, and B6 supplements intended to support muscle preservation and ease side effects. Members track progress with a “Hume Pod” smart scale that separates fat from lean muscle mass, log doses and meals in the Hume Health app, and message their care team through the same app. Dosing is adjusted monthly based on individual results.

bmiMD (bmimd.com) describes itself as a telehealth “managed services organization.” It states it “does not provide medical advice and does not fulfill prescription medication” directly, but facilitates online consultations with licensed physicians across all 50 states and connects patients with third-party pharmacies. Alongside compounded semaglutide, bmiMD offers compounded tirzepatide (a dual GLP-1/GIP medication) in both a standard and a lower-dose “microdose” formulation. Getting started involves an online intake form covering health history and goals, followed by what bmiMD describes as typically a same-day telehealth consultation with a board-certified physician. If approved, medication ships from a “US-based licensed partner pharmacy,” with ongoing 24/7 clinician chat access and monthly check-ins included.

FeelGood (feelgoodmeds.com), operated by FeelGood Holdings, LLC, is an online telehealth platform offering GLP-1 medication for weight loss. It offers three compounded medication options: Semaglutide Injection (from $149/mo), Semaglutide Oral (from $199/mo), and Tirzepatide Injection (from $249/mo). Getting started involves an online intake form and a virtual evaluation with a licensed provider. Nothing is charged unless a provider prescribes treatment, and approved orders ship free within 48 hours of provider approval. Every plan includes unlimited provider messaging, HSA/FSA eligibility, and no membership fees. FeelGood displays a LegitScript-certified pharmacy seal and describes its providers as US-licensed. A telehealth-consent link on FeelGood’s site points to Openloop Health, suggesting a partnership for virtual care and/or compounding, though FeelGood’s own pages don’t elaborate on that relationship.

Gala GLP-1 is an online weight loss and metabolic health service that helps you access prescription GLP-1 treatment from home. Instead of visiting a doctor’s office in person, you complete an online assessment, receive a provider review, and get medication shipped to your door if you qualify. Gala’s weight loss options include compounded GLP-1 treatment, compounded GLP-1/GIP microdosing, and branded Ozempic®. The company also lists Wegovy® pills as coming soon on its weight-loss menu. What makes Gala stand out is its mix of pricing, simplicity, and support. You can choose lower-cost compounded options, a branded medication route, or a gentler microdosing plan if you want metabolic benefits without aggressive weight loss. Gala also promotes provider visits, free shipping, cancellation anytime, ongoing support, and a full refund if a medical provider disqualifies you for medical reasons.

Sunlight is a telehealth weight-loss platform designed for adults who want access to GLP-1 treatment without the long wait times, insurance complications, or confusing pricing that often come with traditional medical care. Instead of trying to book multiple in-person appointments, you complete an online intake process, choose your treatment, and have your information reviewed by a licensed clinician. If you qualify, your prescription can be processed and shipped to your home. The service focuses on compounded semaglutide and tirzepatide, with plans that include medication, unlimited telehealth support, free shipping, and dosage adjustments. You also get a simple self-pay model, which means you do not need insurance to begin. Sunlight positions itself as a transparent, easy-to-use option for personalized GLP-1 weight loss support, especially if you want online care, home delivery, and predictable monthly pricing.